bioAffinity Technologies, Inc. (BIAF)
$8.85+$3.50 (+65.42%) Latest session
bioAffinity Technologies Inc develops noninvasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis informed by machine learning, a form of artificial intelligence (AI). Its first commercial diagnostic test, CyPath Lung, identifies and analyzes cell populations using flow cytometry, including cancer and cancer-related cells, that indicate a malignancy in the lung. It is developing its flow cytometry platform to address the need to identify patients who can benefit from new and emerging therapies for asthma and chronic obstructive pulmonary disease with noninvasive precision diagnostic tests. The company is organized in two operating segments, Diagnostic Research and Development and Laboratory Services.
https://www.bioaffinitytech.comSEC filings for BIAF on EDGAR
No Form 4 activity for BIAF in the last 90 days.
1 Form 4 filing on record, the earliest from Nov 5, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| James Michael Edwards - Officer | Grant or award | Common Stock | 100,000 | $0.00 | - |
bioAffinity Technologies, Inc. (BIAF) has filed no insider reports in the last 90 days. The most recent on record is dated 2024-11-05. The full record for BIAF runs to 1 Form 4 filing, the earliest from 2024-11-05. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of BIAF were filed in the last 90 days.
No insider sales of BIAF were filed in the last 90 days.
This page tracks BIAF Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add BIAF to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
